keyword
https://read.qxmd.com/read/38141029/the-change-in-fibrosis-4-index-in-japanese-patients-with-type%C3%A2-2-diabetes-treated-by-a-fixed-ratio-combination-therapy-of-insulin-degludec-and-liraglutide-a-retrospective-observational-study
#21
JOURNAL ARTICLE
Hiroyuki Ito, Ryota Someya, Shigenori Ando, Rie Araki, Emiko Tsugami, Suzuko Matsumoto, Hideyuki Inoue, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori, Michiko Togane
AIM: The efficacy of titratable fixed-ratio combination therapy by a combination preparation of insulin degludec and liraglutide (IDegLira) in Japanese patients with type 2 diabetes, focusing particularly on the change in Fibrosis-4 index (FIB-4), a noninvasive method for the evaluation of liver fibrosis, was investigated. METHODS: As the full analysis set, 113 patients were treated with IDegLira. The patients were categorized into two groups according to the absence (GLP-1RA-naïve group, n = 72) or presence (GLP-1RA-treated group, n = 41) of glucagon-like peptide-1 receptor agonist (GLP-1RA) use before starting IDegLira...
December 23, 2023: Hepatology Research: the Official Journal of the Japan Society of Hepatology
https://read.qxmd.com/read/38125205/glucagon-like-peptide-1-receptor-agonist-and-sodium-glucose-cotransporter-2-inhibitor-use-among-adults-with-diabetes-mellitus-by-cardiovascular-kidney-disease-risk-national-health-and-nutrition-examination-surveys-2015-2020
#22
JOURNAL ARTICLE
Joshua A Jacobs, Alexander R Zheutlin, Catherine G Derington, Jordan B King, Ambarish Pandey, Adam P Bress
OBJECTIVE: Glucagon-like peptide-1 receptor agonists (GLP1-RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2Is) lower adverse cardiac and kidney events among high-risk patients with diabetes mellitus (DM) and are now guideline-recommended as first-line therapy alongside metformin. However, the adoption of these new treatments from 2015 to 2020 among the highest-risk adults with DM remains unclear. METHODS: We performed a cross-sectional analysis of the National Health and Nutrition Examination Surveys (NHANES) 2015-2020 to estimate the use of GLP1-RAs and SGLT2Is among adults with DM overall and by level of cardiovascular and kidney risk (CKR)...
March 2024: American journal of preventive cardiology
https://read.qxmd.com/read/38043334/neuroprotective-effects-of-oral-metformin-before-stroke-on-cerebral-small-vessel-disease
#23
JOURNAL ARTICLE
Natsuki Akiyama, Takayuki Yamashiro, Itaru Ninomiya, Masahiro Uemura, Yorito Hattori, Masafumi Ihara, Osamu Onodera, Masato Kanazawa
BACKGROUND: Metformin (MET) treatment prior to stroke might have neuroprotective effects other than hypoglycemic effects. This study evaluated whether MET treatment prior to stroke is associated with neurological severity and functional outcome in patients with stroke who were not indicated for endovascular treatment and whether the effects of MET differ for each ischemic stroke subtype. METHODS: We investigated 160 type 2 diabetes mellitus patients with ischemic stroke without endovascular treatment who were taking some oral antidiabetic agents prior to stroke in two tertiary hospitals...
November 30, 2023: Journal of the Neurological Sciences
https://read.qxmd.com/read/38038273/zinc-phthalocyanine-loaded-plga-pva-chitosan-nanosystem-for-the-enhancement-of-antidiabetic-activity
#24
JOURNAL ARTICLE
Sharayu Govardhane, Pravin Shende
Zinc, one of the most common nutraceutical agents, proved to be effective for diabetes as it regulates the blood glucose level by inhibiting glucagon secretion. However, the hepatotoxicity of zinc creates necrosis, hepatic glycogen depletion, and apoptosis of hepatocytes at the concentration of 10 μg/kg. Phthalocyanine, a blue-colored compound, is an aromatic macrocyclic compound with good antioxidant ability owing to its heterocyclic nitrogen conjugation. The conjugation of zinc with phthalocyanine aimed to reduce the toxicity associated with zinc and enhance the antidiabetic activity at a lower dose...
December 1, 2023: Molecular Pharmaceutics
https://read.qxmd.com/read/38038009/alkaloids-as-promising-agents-for-the-management-of-insulin-resistance-a-review
#25
JOURNAL ARTICLE
Mohamed Eddouks, Ayoub Amssayef
BACKGROUND: Insulin resistance is one of the main factors that lead to the development of type 2 diabetes mellitus (T2DM). The effect of alkaloids on insulin resistance has been extensively examined according to multiple scientific researches. OBJECTIVE: In this work, we aimed to summarize the interesting results from preclinical and clinical studies that assessed the effects of natural alkaloids (berberine, nigelladine A, piperine, trigonelline, capsaicin, nuciferine, evodiamine, mahanine, and magnoflorine) on impaired insulin sensitivity and worsened insulin resistance, which play a pivotal role in the pathogenesis of type 2 diabetes...
November 30, 2023: Current Pharmaceutical Design
https://read.qxmd.com/read/38022370/insulin-requirements-during-severe-covid-19-were-relatively-low-in-japanese-patients-with-type-2-diabetes-two-case-reports
#26
Junpei Yamamoto, Hironobu Takahashi, Takaharu Saito, Yuri Yamamoto, Koudai Takahashi, Koji Itakura, Makoto Kobayashi, Ryotaro Igusa, Takafumi Kobayashi, Masakazu Ichinose, Masahiro Usui
The global coronavirus disease 2019 (COVID-19) pandemic has caused myriad adverse effects on the pathology of other diseases. Numerous studies on COVID-19 have reported that, in patients with type 2 diabetes mellitus (T2DM) who have contracted severe COVID-19, glucose metabolism is exacerbated by multiple factors, such as severe inflammation, beta-cell dysfunction caused by the SARS-CoV-2 infection itself, corticosteroid therapy, vasopressor administration, and enteral or parenteral nutrition. Very high doses of insulin are often required in the acute phase of such patients; however, the factors that affect insulin requirements and to what extent remain unclear...
October 2023: Curēus
https://read.qxmd.com/read/38004427/chitosan-nanoparticles-for-enhanced-delivery-of-sida-cordifolia-extract-formulation-optimization-and-bioactivity-assessment
#27
JOURNAL ARTICLE
Perwez Alam, Mohd Imran, Shahnawaz Ahmed, Haya Majid, Ali Akhtar
In a continuous search for an essential antidiabetic agent, Sida cordifolia hydroalcoholic (SCHA) extract-loaded chitosan nanoparticles (SCHA-CS-NP) were optimized. The Box-Behnken design (BBD Design-Expert software, version 14) with three parameters was used to optimize the nanoparticles after creating them using the ion gelation method. The chitosan and Tween 20 contents and the stirring speed were chosen as the independent variables, and their separate and combined effects on particle size (Y1), polydispersity index (Y2) and entrapment efficiency (Y3) were observed...
November 6, 2023: Pharmaceuticals
https://read.qxmd.com/read/37969920/cheminformatics-identification-of-modulators-of-key-carbohydrate-metabolizing-enzymes-from-c-cujete-for-type-2-diabetes-mellitus-intervention
#28
JOURNAL ARTICLE
Fatai Oladunni Balogun, Karishma Singh, Athika Rampadarath, Ayesha Akoonjee, Kayleen Naidoo, Saheed Sabiu
PURPOSE: The therapeutic use of oral hypoglycaemic agents in the management of type-2 diabetes mellitus (T2DM) is without adverse effects; thus, calls for alternative and novel candidates from natural products in medicinal plants. METHOD: The study explored molecular docking and molecular dynamics (MD) simulation approaches to identify key antidiabetic metabolites from Crescentia cujete . RESULTS: Molecular docking results identified four and/or five best compounds against each target enzyme (alpha-glucosidase, dipeptidyl peptidase-IV, aldose reductase, and protein tyrosine phosphatase-1B (PTP-1B)) implicated in diabetes...
December 2023: Journal of Diabetes and Metabolic Disorders
https://read.qxmd.com/read/37873913/in-silico-assessment-of-polyherbal-oils-as-anti-diabetic-therapeutics
#29
JOURNAL ARTICLE
Amul S Bahl, Vipin Kumar Verma, Vaishali Prajapati, Jagriti Bhatia, Dharamvir Singh Arya
BACKGROUND: Diabetes mellitus (DM) is characterized by elevated blood glucose levels either due to insufficient insulin production, defective insulin action, or both. It affects nearly 537 million individuals worldwide. Pharmacological treatment involves the use of oral antidiabetic agents as mono or combination therapy that effectively aids in controlling hyperglycemia. Despite providing therapeutic benefits, these medications limit their use owing to adverse side effects. Certain natural products, including essential oils, have promising anti-diabetic properties...
October 23, 2023: Current Computer-aided Drug Design
https://read.qxmd.com/read/37857970/-type-2-diabetes-choosing-antidiabetic-therapy-depending-on-comorbidities
#30
JOURNAL ARTICLE
Baptist Gallwitz
No abstract text is available yet for this article.
October 2023: MMW Fortschritte der Medizin
https://read.qxmd.com/read/37855361/characteristics-and-biological-properties-of-imeglimin-hydrochloride-a-novel-antidiabetic-agent-a-systematic-review
#31
JOURNAL ARTICLE
Jasira Sultan, Nikhil Agarwal, Sanjay Sharma
BACKGROUND: WHO indicates that diabetes will become the 7th leading reason for death by 2030. The physiopathology of dysfunctioning is associated with obesity, weight gain and predominantly insulin resistance in insulin-sensitive cells and continuous deterioration of pancreatic beta cell function. Imeglimin is an investigational novel oral anti-diabetic drug Objectives: The motive of the review is to comprehensively explore the chemistry, biological and analytical analysis of the Imeglimin hydrochloride...
October 17, 2023: Current Diabetes Reviews
https://read.qxmd.com/read/37833402/baseline-treatments-and-metabolic-control-of-288-913-type-2-diabetes-patients-in-a-10-year-retrospective-cohort-in-malaysia
#32
JOURNAL ARTICLE
Kim Sui Wan, Feisul Mustapha, Arunah Chandran, Shubash Shander Ganapathy, Nurhaliza Zakariah, Sivarajan Ramasamy, Gunenthira Rao Subbarao, Muhammad Fadhli Mohd Yusoff
Diabetes is one of the quickest-growing global health emergencies of the twenty-first century, and data-driven care can improve the quality of diabetes management. We aimed to describe the formation of a 10-year retrospective open cohort of type 2 diabetes patients in Malaysia. We also described the baseline treatment profiles and HbA1c, blood pressure, and lipid control to assess the quality of diabetes care. We used 10 years of cross-sectional audit datasets from the National Diabetes Registry and merged 288,913 patients with the same identifying information into a 10-year open cohort dataset...
October 13, 2023: Scientific Reports
https://read.qxmd.com/read/37831720/blood-pressure-lowering-effects-of-vernonia-amygdalina-del-aqueous-fraction-on-hypertensive-wistar-kyoto-rats
#33
JOURNAL ARTICLE
Dian Ayu Juwita, Rindang Farinka, Rahmad Abdillah, Fitri Rachmaini
OBJECTIVES: Vernonia amygdalina (VA) is a plant that consumed as vegetable by Indonesians contained numerous secondary metabolites. VA's pharmacological action, including its antioxidant properties, anticancer, antidiabetic, and hepatoprotective. The purpose of this research is to reveal the activity of Vernonia amygdalina . leafs aqueous fraction (VALAF) as a blood pressure-lowering agent in hypertensive model. METHODS: Combination of Prednisone and NaCl were used as hypertensive inducer...
October 16, 2023: Journal of Complementary & Integrative Medicine
https://read.qxmd.com/read/37804691/utilization-and-impact-of-slgt2-inhibitors-among-diabetes-patients-in-a-nationally-representative-survey-findings-from-nhanes-2013-2020
#34
JOURNAL ARTICLE
Tsung-Hua Shen, Joel F Farley
BACKGROUND AND AIMS: The purpose of this study is to examine patterns of utilization for antidiabetic medications among a nationally representative sample of the US population following the introduction of SGLT2 inhibitors in 2013. METHODS: The study utilized National Health and Nutrition Examination Survey (NHANES) data from 2013 to 2020 to identify adult patients with diabetes using antidiabetic medication. The proportion of patients with diabetes using different antidiabetic medications, including SGLT2 inhibitors, was plotted over time...
November 2023: Journal of Diabetes and its Complications
https://read.qxmd.com/read/37781463/use-of-diabetes-medications-in-adults-with-t2d-and-cvd-in-japan-secondary-analysis-of-the-capture-study
#35
JOURNAL ARTICLE
Yukiko Onishi, Shinichiro Shirabe, Kosei Eguchi, Keiji Nishijima, Toshihiro Sato, Hiroaki Seino
INTRODUCTION: The CAPTURE study estimated the global prevalence of established cardiovascular disease (CVD) and characterized the usage of glucose-lowering agents (GLAs) in adults with type 2 diabetes (T2D) across 13 countries. The purpose of this secondary analysis of data from the Japanese sites within CAPTURE (NCT03786406, NCT03811288) was to provide data about medication usage stratified by CVD status among Japanese participants with T2D. MATERIALS AND METHODS: Data on GLA usage (including those with proven cardiovascular [CV] benefits) in Japanese participants with T2D managed in clinics or hospitals were collected and stratified by CVD subgroups...
October 2023: Diabetology International
https://read.qxmd.com/read/37768731/low-density-lipoprotein-cholesterol-is-not-a-major-determinant-of-high-sensitivity-c-reactive-protein-levels-in-people-without-known-diabetes-mellitus
#36
JOURNAL ARTICLE
Guan-Yu Su, Ng Xin Ning, Kuan-Hung Lin, Chii-Min Hwu
Background: It has been well established that high-sensitivity C-reactive protein (hs-CRP) is strongly associated with obesity, insulin resistance, high blood pressure, and dyslipidemia. However, the effects of different lipid parameters on hs-CRP levels are less deliberated. The purpose of the study was to compare the relative contribution of triglycerides (TGs), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) to the levels of hs-CRP. Methods: Three hundred seventy-eight subjects without known history of diabetes were recruited for the study...
December 2023: Metabolic Syndrome and related Disorders
https://read.qxmd.com/read/37740048/impact-of-type-2-diabetes-mellitus-and-insulin-use-on-progression-to-glaucoma-surgery-in-primary-open-angle-glaucoma
#37
JOURNAL ARTICLE
Michelle T Sun, Suzann Pershing, Jeffrey L Goldberg, Sophia Y Wang
PURPOSE: To investigate outcomes of primary open-angle glaucoma (POAG) patients with and without type 2 diabetes mellitus (T2DM). METHODS: Retrospective observational study using U.S. nationwide healthcare insurance claims database. Patients ≥40 years old with at least one HbA1c within one year of POAG diagnosis were included. Diabetic factors associated with POAG progression requiring glaucoma surgery were evaluated using multivariable Cox proportional hazards regression models adjusted for demographic, diabetic and glaucoma factors...
September 22, 2023: Eye
https://read.qxmd.com/read/37682449/the-current-place-of-dpp4-inhibitors-in-the-evolving-landscape-of-type-2-diabetes-management-is-it-time-to-bid-adieu
#38
JOURNAL ARTICLE
Theocharis Koufakis, Ioanna Zografou, Michael Doumas, Kalliopi Kotsa
During the last decade, the landscape of type 2 diabetes (T2D) management has been completely transformed, moving from a glucose-centric perspective to a holistic approach that also takes into account weight control and organ protection. Dipeptidyl peptidase-4 inhibitors (DPP4i) are oral agents that have been used for the treatment of T2D for almost 20 years. Although they present an excellent safety profile, including the risk of hypoglycemia, they lack the spectacular cardiorenal benefits and weight-loss effects of the newer antidiabetic agents...
November 2023: American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions
https://read.qxmd.com/read/37623224/antidiabetic-effect-of-fermented-mesembryanthemum-crystallinum-l-in-db-db-mice-involves-regulation-of-pi3k-akt-pathway
#39
JOURNAL ARTICLE
Hye-Lin Kim, Yunu Jung, Hyo In Kim, Nak-Yun Sung, Min-Jee Kim, In-Jun Han, Geon Kim, Eun Yeong Nho, Sang-Yun Park, Yohan Han, Ji Hoon Jung, Dong-Sub Kim, Jinbong Park
Type 2 diabetes (T2D) is a serious health issue with increasing incidences worldwide. However, current medications have limitations due to side effects such as decreased appetite, stomach pain, diarrhea, and extreme tiredness. Here, we report the effect of fermented ice plant (FMC) in the T2M mouse model of db / db mice. FMC showed a greater inhibition of lipid accumulation compared to unfermented ice plant extract. Two-week oral administration with FMC inhibited body weight gain, lowered fasting blood glucose, and improved glucose tolerance...
August 3, 2023: Current Issues in Molecular Biology
https://read.qxmd.com/read/37612867/antidiabetic-effect-of-star-anise-illicium-verum-in-streptozotocin-induced-diabetic-rats
#40
JOURNAL ARTICLE
Smail Amtaghri, Adil Qabouche, Miloudia Slaoui, Mohamed Eddouks
AIM: The current study aimed to evaluate the antidiabetic potential of Illicium verum fruits. BACKGROUND: Illicium verum fruits are frequently used by the Moroccan population in the treatment of diabetes. METHODS: The antihyperglycemic effect of the aqueous extract of Illicium verum fruits (AEIVF) in rats was assessed. The effects of AEIVF (20 mg/kg) on glycemia and lipid profile as well as its phytochemical and antioxidant properties were evaluated...
August 23, 2023: Cardiovascular & Hematological Disorders Drug Targets
keyword
keyword
72007
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.